5-Thiazolecarboxylic Acid, 4-Bromo-, Ethyl Ester

Addition of 2.5 mol% Pd(dba)₂ combined with 5 mol% SPhos in degassed THF at 45 °C initiates oxidative insertion into the C–Br bond of 5-thiazolecarboxylic acid, 4-bromo-, ethyl ester. The reaction profile is acutely sensitive to water content; residual moisture above 200 ppm triggers premature ester hydrolysis, reducing active substrate concentration and generating the free 4-bromo-5-thiazolecarboxylic acid, which poisons the catalytic cycle via stable palladium carboxylate formation. On production-scale equipment with 316L stainless steel reactors and an L/D ratio for overhead condensers exceeding 8:1, batch-to-batch cross-coupling yields have been observed to fluctuate by 12–18% when the inert gas purge rate falls below 0.8 vvm. The optimal stoichiometry couples 1.03 eq of (4-fluorophenyl)boronic acid with the bromoester using 1.5 eq anhydrous K₃PO₄ milled to a mean particle size of 45 µm. Post-reaction scavenging of residual palladium with 3 wt% Trimercaptotriazine-functionalized silica gel at 60 °C for 4 h consistently reduces Pd content below 10 ppm, meeting the oral solid-dosage metal impurity thresholds of ICH Q3D Step 4. The resulting 4-(4-fluorophenyl)thiazole-5-carboxylate intermediate, after saponification and coupling to a chiral morpholine amide, yields a preclinical tropomyosin receptor kinase (Trk) inhibitor analog documented to require 99.5% enantiomeric excess as measured by chiral HPLC with amylose tris(3,5-dimethylphenylcarbamate) stationary phase. All synthetic steps executed under cGMP for phase I material comply with 21 CFR 210 and 211; residual solvent levels in the ethyl ester intermediate are controlled to < 5000 ppm for THF and < 600 ppm for 1,4-dioxane per USP ⟨467⟩ Option 2.

Thiazole-5-carboxylic acid, 4-bromo-, ethyl ester serves as the electrophilic partner in palladium-mediated direct arylation of 3-alkylthiophenes without pre-functionalized organometallic reagents. The process is executed in anhydrous N,N-dimethylacetamide with 2.0 eq pivalic acid as proton shuttle and 3 mol% Pd(OAc)₂ in combination with 30 mol% tris(2-furyl)phosphine, heated to 110 °C under nitrogen blanket for 18 h. The absence of organoboron reagents eliminates the associated halide salt waste stream, but introduces a competing debromination pathway that forms ethyl 5-thiazolecarboxylate as a critical impurity. At temperatures exceeding 115 °C, the debrominated byproduct reaches 7% area by GC-FID, necessitating a tightly controlled jacket temperature setpoint with a proportional-integral-derivative cascade tuned to a response time constant of 12 s. The crude product is isolated by drowning the reaction mixture into 8 volumes of deionized water at 0–5 °C, followed by reslurrying in isopropanol/water (7:3 v/v) to remove coordinated palladium species. The 4-(hetero)arylated ester then enters a hydrazinolysis sequence—suspended in ethanol, treated with 1.2 eq hydrazine monohydrate at 40 °C—to furnish the corresponding hydrazide, a key intermediate in the production of 2-aminothiazole-linked pyrazole agrochemical leads undergoing field trials against sclerotinia stem rot. Pre-shipment quality control for export batches destined for EU receiving operations includes verification that any single unidentified impurity exceeding 0.10% be structurally characterized per REACH Annex VII and a Declaration of Non-Use for Substances of Very High Concern (SVHCs) beyond 0.1% w/w be on file.

What Limits the Retention of the Ethyl Ester Throughout the Synthetic Sequence in Contrast to Methyl Ester Congeners?

When 5-thiazolecarboxylic acid, 4-bromo-, ethyl ester is converted into ligands for organometallic frameworks, deliberate preservation of the ester moiety through to the penultimate step is structurally mandatory. The ethyl ester group exhibits a hydrolytic half-life that is 3.5 times longer than its methyl analogue under the slightly acidic aqueous conditions (pH 5.0–5.5) generated by the release of HBr during palladium coordination, as measured by in situ ReactIR at 1738 cm⁻¹. To access bis(oxazoline)thiazole (ThiazBOX) ligands, two equivalents of the bromoester are coupled to a central 1,3-diyne core. The Sonogashira coupling protocol requires the pre-formation of a copper acetylide from 1.6 eq trimethylsilylacetylene, desilylated with 1.5 eq tetrabutylammonium fluoride trihydrate, and then cross-coupled with the bromoester using 1.8 mol% Pd(PPh₃)₄ and 3.6 mol% CuI in triethylamine at 55 °C for 6 h. The ethyl ester’s steric shielding of the carbonyl carbon attenuates nucleophilic attack by the triethylamine, suppressing amidation side products to below 1.2%. The resulting diester-diyne intermediate is reduced to the saturated linker with 10% Pd/C under 4 bar H₂, and then subjected to amidine cyclization with 2.5 eq amino alcohol in chlorobenzene at 130 °C. The final ThiazBOX-ethyl ester is complexed with Cu(OTf)₂ in acetonitrile to generate an asymmetric cyclopropanation catalyst, achieving 94% enantiomeric excess for the benchmark reaction of styrene with ethyl diazoacetate as verified by chiral GC (Chirasil-Dex CB column, 25 m × 0.25 mm, isothermal 80 °C). Every shipment of the bromoester destined for this ligand application is accompanied by a certificate of analysis reporting an ester hydrolysis specification of less than 0.5% as determined by potentiometric titration with 0.1 N tetrabutylammonium hydroxide in methanol.

In the synthesis of chemical probes for target engagement studies, the bromine atom at the 4-position of the thiazole ring is exploited for late-stage functionalization via lithium-halogen exchange, circumventing palladium entirely. The protocol mandates anhydrous 2-methyltetrahydrofuran stabilized with 250–350 ppm BHT, cooled to −78 °C by a jacketed reactor with liquid nitrogen circulation, and a controlled titration of 1.07 eq n-butyllithium (2.5 M in hexanes) at a rate that maintains internal temperature below −68 °C. The resulting 4-lithio species is quenched immediately—residence time in the lithiated state exceeding 45 s leads to ring-opening fragmentation detected by a color shift to deep amber—with 1.2 eq of electrophile (e.g., N-fluorobenzenesulfonimide for installing a ¹⁹F label, or deuterium oxide for isotopic coding). When the electrophile is 1.05 eq of diethyl chlorophosphate, the resultant 4-phosphonatothiazole-5-carboxylic acid ethyl ester after trimethylsilyl bromide deprotection yields a bioisostere of phosphotyrosine incorporated into SH2 domain-binding peptides. The final peptide conjugate, after cleavage from 2-chlorotrityl chloride resin (loading 0.9 mmol/g) and purification via preparative RP-HPLC on a C18 column (pore size 100 Å, particle size 5 µm), achieves a purity of 98.7% defined by integration at 220 nm. Cold-chain logistics (+2 to +8 °C) are required for peptide shipments owing to the proclivity of the phosphonothiazole moiety to undergo des-esterification at ambient temperature over 72 h, as evidenced by a 6.8% increase in free acid by LC-MS. The manufacturing site is certified to ISO 9001:2015 and handles this intermediate under an internal specification for genomic DNA residue below 100 pg/mg (qPCR method, E. coli host cell DNA assay).

Process windows where the bromoester behaves as a bromine donor in Negishi-type polyheterocycle assembly

The zinc insertion into 5-thiazolecarboxylic acid, 4-bromo-, ethyl ester proceeds with activated zinc dust (batch-average surface area 0.8 m²/g) pretreated with 2 mol% chlorotrimethylsilane and 0.5 mol% 1,2-dibromoethane in THF at 35 °C. The resultant organozinc species, employed without isolation, cross-couples with 0.95 eq of 2-chloro-5-iodopyrimidine in the presence of 1.5 mol% Pd(dppf)Cl₂·CH₂Cl₂ and 3 mol% CuI at 50 °C for 90 min. The reaction intensifies the structural complexity of the final heterocyclic scaffold—2-(thiazol-5-yl)pyrimidine-4-carbonitrile derivatives that act as stearoyl-CoA desaturase 1 (SCD1) inhibitors—without isolating the intermediate organozincate, reducing the total process mass intensity (PMI) to 32.5. A plant-scale failure mode reported during pilot campaigns involved spontaneous heating of the zinc insertion batch when the THF supernate water content exceeded 300 ppm due to inadequately regenerated molecular sieves of type 3A, triggering a runaway exotherm reaching 68 °C and degrading 18% of the bromoester within 8 min. Corrective actions instituted a differential scanning calorimetry (DSC) criterion: no batch of activated zinc is released until a thermogram (ramp rate 10 °C/min, N₂ atmosphere) confirms onset temperature for uncontrolled decomposition above 150 °C. The final pharmaceutical intermediate must not contain more than 3 ppm of elemental zinc, measured by inductively coupled plasma mass spectrometry (ICP-MS), to satisfy the permitted daily exposure (PDE) of 1.3 mg/day for parenteral products per ICH Q3D guideline on elemental impurities.

Employed as a key input for the construction of fluorescent small-molecule probes, the ethyl ester is reacted under modified Sandmeyer conditions to replace the bromine with an azido group without reducing the adjacent ester. The sequence involves treatment with 1.5 eq sodium azide and 0.15 eq copper(I) iodide promoted by 0.2 eq N,N′-dimethylethylenediamine in DMSO-water (5:1) at 60 °C for 8 h, shielded from light. The 4-azidothiazole-5-carboxylate intermediate then undergoes copper(I)-catalyzed alkyne-azide cycloaddition (CuAAC) with an alkyne-functionalized dansyl or BODIPY fluorophore using 10 mol% CuSO₄·5H₂O and 20 mol% sodium ascorbate in tert-butanol/water at 25 °C for 12 h. The labeling efficiency under these conditions is quantitated at 92 ± 3% as assessed by reverse-phase HPLC fluorescence (ex/em: 340/535 nm). The molar extinction coefficient of the final thiazole-linked BODIPY conjugate at 502 nm in ethanol is specified as ≥ 76,000 L·mol⁻¹·cm⁻¹, per the analytical QC protocol adopting the Lambert-Beer method with NIST-traceable absorbance standard SRM 930e. However, the use of sodium azide on scale mandates compliance with explosion risk assessments: all stirred vessels employed up to the azide intermediate isolation must pass a detonation propagation test (UN IHE DDT) with a limiting charge diameter of less than 0.6 mm for the copper azide complex. Waste aqueous phases are treated with 0.3% w/v ceric ammonium nitrate at pH 9.0 to destroy residual azide anions prior to sewer discharge.

When the 4-Bromo Substituent Serves as a Handhold for Catalytic Enantioselective C–H Functionalization in Complex Natural Product Re-engineering

5-Thiazolecarboxylic acid, 4-bromo-, ethyl ester is subjected to asymmetric C–H hydroxylation at the unactivated 2-position while retaining the bromine and ester intact. Using a bio-mimetic manganese catalyst based on Mn(CF₃SO₃)₂ with a chiral bis(oxazoline) ligand derived from (S,S)-diphenylethylenediamine (5 mol% Mn, 7 mol% ligand), hydrogen peroxide (2.5 eq, 30% aqueous solution added over 3.5 h via syringe pump) oxidizes the ring in acetonitrile at −10 °C. Under these controlled conditions, the mono-hydroxylated 2-hydroxythiazole derivative was obtained with 86% ee and 68% isolated yield after flash chromatography (silica 60, gradient elution hexane/ethyl acetate). Incorporating this chiral hydroxy-thiazole core into a synthetic intermediate for discodermolide-inspired microtubule stabilizers demands that the ee be upgraded to ≥ 99% by diastereomeric salt resolution with (1S)-(+)-10-camphorsulfonic acid at a ratio of 1.05 eq in refluxing 2-butanone. The resolved hydroxyester is then O-alkylated with 1.1 eq of a preformed nosylate electrophile in DMF with 1.5 eq Cs₂CO₃ at 40 °C, furnishing the fully elaborated scaffold for linker attachment. The entire sequence demonstrated mass recovery exceeding 72% over four telescoped steps, verified by on-line HPLC PAT at 245 nm. All samples shipped for pharmacology screening are accompanied by a Certificate of Compliance to the Nagoya Protocol on access to genetic resources, as the final target compounds are analogues of sponge-derived polyketides.